Literature DB >> 21861699

Critical cytokine pathways to cardiac inflammation.

Noel R Rose1.   

Abstract

Infectious disease is frequently cited as a precursor of subsequent autoimmune disease in genetically susceptible hosts. However, the precise mechanisms required for the transition from infection to autoimmunity have not been well defined. We have developed a mouse model of autoimmune myocarditis initiated by infection with Coxsackievirus B3 to trace the cytokine pathways involved. We found that greater production of interleukin-1β (IL-1β) and tumor necrosis factor-α during the early innate response to virus infection is necessary and sufficient to induce a later heart-specific autoimmune disease. Severity of the autoimmune myocarditis is determined by the profile of a number of T helper 1 (Th1) and Th2 cytokines. Th2 responses are especially pronounced in the most severe forms of myocarditis where eosinophils are prominent. The Th1 pathway can lead to infiltration of the heart, but may be dampened by concurrent INF-γ production. Th17 cytokines also contribute to disease, but the signature Th17 cytokine, IL-17A, is not required for cardiac inflammation. Rather, IL-17A is needed for progression to dilated cardiomyopathy. These findings may provide useful markers to identify individuals prone to develop an autoimmune sequel after infection and suggest future early interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21861699      PMCID: PMC3189548          DOI: 10.1089/jir.2011.0057

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  30 in total

Review 1.  Molecular mimicry: a critical look at exemplary instances in human diseases.

Authors:  N R Rose; I R Mackay
Journal:  Cell Mol Life Sci       Date:  2000-04       Impact factor: 9.261

Review 2.  Viral damage or 'molecular mimicry'-placing the blame in myocarditis.

Authors:  N R Rose
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

3.  Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype.

Authors:  M Afanasyeva; Y Wang; Z Kaya; S Park; M J Zilliox; B H Schofield; S L Hill; N R Rose
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway.

Authors:  M Afanasyeva; Y Wang; Z Kaya; E A Stafford; K M Dohmen; A A Sadighi Akha; N R Rose
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

5.  Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.

Authors:  G Christian Baldeviano; Jobert G Barin; Monica V Talor; Sachin Srinivasan; Djahida Bedja; Dongfeng Zheng; Kathleen Gabrielson; Yoichiro Iwakura; Noel R Rose; Daniela Cihakova
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

6.  Coxsackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains.

Authors:  A Herskowitz; L J Wolfgram; N R Rose; K W Beisel
Journal:  J Am Coll Cardiol       Date:  1987-06       Impact factor: 24.094

Review 7.  Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Noel R Rose
Journal:  Rev Med Virol       Date:  2005 Jan-Feb       Impact factor: 6.989

8.  Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis.

Authors:  J R Lane; D A Neumann; A Lafond-Walker; A Herskowitz; N R Rose
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

Review 9.  Pathogenesis of myocarditis and dilated cardiomyopathy.

Authors:  Daniela Cihakova; Noel R Rose
Journal:  Adv Immunol       Date:  2008       Impact factor: 3.543

10.  Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis.

Authors:  L J Wolfgram; K W Beisel; N R Rose
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  26 in total

Review 1.  Viral myocarditis.

Authors:  Noel R Rose
Journal:  Curr Opin Rheumatol       Date:  2016-07       Impact factor: 5.006

2.  Downregulation of chicken interleukin-17 receptor A during Eimeria infection.

Authors:  Woo H Kim; Jipseol Jeong; Ae R Park; Dongjean Yim; Suk Kim; Hong H Chang; Seung-Hak Yang; Dong-Hee Kim; Hyun S Lillehoj; Wongi Min
Journal:  Infect Immun       Date:  2014-06-30       Impact factor: 3.441

Review 3.  Cytokines in autoimmunity: role in induction, regulation, and treatment.

Authors:  Kamal D Moudgil; Divaker Choubey
Journal:  J Interferon Cytokine Res       Date:  2011-09-23       Impact factor: 2.607

4.  Galectin-3 deficiency enhances type 2 immune cell-mediated myocarditis in mice.

Authors:  Marina Miletic Kovacevic; Nada Pejnovic; Slobodanka Mitrovic; Nemanja Jovicic; Ivica Petrovic; Nebojsa Arsenijevic; Miodrag L Lukic; Biljana Ljujic
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

Review 5.  Update on coxsackievirus B3 myocarditis.

Authors:  DeLisa Fairweather; Katelyn A Stafford; Yoon K Sung
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

Review 6.  Bioanalytical chemistry of cytokines--a review.

Authors:  Julie A Stenken; Andreas J Poschenrieder
Journal:  Anal Chim Acta       Date:  2014-10-12       Impact factor: 6.558

7.  Transplantation of autologously derived mitochondria protects the heart from ischemia-reperfusion injury.

Authors:  Akihiro Masuzawa; Kendra M Black; Christina A Pacak; Maria Ericsson; Reanne J Barnett; Ciara Drumm; Pankaj Seth; Donald B Bloch; Sidney Levitsky; Douglas B Cowan; James D McCully
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-25       Impact factor: 4.733

8.  Increased systemic Th17 cytokines are associated with diastolic dysfunction in children and adolescents with diabetic ketoacidosis.

Authors:  William H Hoffman; Gregory G Passmore; David W Hannon; Monica V Talor; Pam Fox; Catherine Brailer; Dynita Haislip; Cynthia Keel; Glenn Harris; Noel R Rose; Irma Fiordalisi; Daniela Čiháková
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

Review 9.  T-cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation.

Authors:  E Stephenson; K Savvatis; S A Mohiddin; F M Marelli-Berg
Journal:  Br J Pharmacol       Date:  2016-10-04       Impact factor: 8.739

10.  COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation.

Authors:  Abby C Lee; Grant Castaneda; Wei Tse Li; Chengyu Chen; Neil Shende; Jaideep Chakladar; Pam R Taub; Eric Y Chang; Weg M Ongkeko
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.